The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ATARA BIOTHERAPEUTICS INC | COM | 046513107 | 15,760 | 1,000,000 | SH | DFND | 1,000,000 | 0 | 0 | ||
| CARDLYTICS INC | COM | 14161W105 | 42,218 | 638,800 | SH | DFND | 638,800 | 0 | 0 | ||
| CAREMAX INC | COM CL A | 14171W103 | 4,608 | 600,000 | SH | DFND | 600,000 | 0 | 0 | ||
| CARVANA CO | CL A | 146869102 | 93,875 | 405,000 | SH | DFND | 405,000 | 0 | 0 | ||
| CLARIVATE PLC | ORD SHS | G21810109 | 8,820 | 375,000 | SH | DFND | 375,000 | 0 | 0 | ||
| SEA LTD | SPONSORD ADS | 81141R100 | 78,299 | 350,000 | SH | DFND | 350,000 | 0 | 0 | ||